Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
85.69
-1.40 (-1.61%)
At close: Sep 25, 2026, 4:00 PM EDT
85.69
0.00 (0.00%)
After-hours: Sep 25, 2026, 7:30 PM EDT
Spyre Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
125
Market Cap
7.56B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 886.00K | -1.44M | -61.96% |
| Dec 31, 2022 | 2.33M | -16.41M | -87.57% |
| Dec 31, 2021 | 18.74M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Caris Life Sciences | 989.61M |
| Ionis Pharmaceuticals | 874.09M |
| TG Therapeutics | 799.54M |
| Protagonist Therapeutics | 281.99M |
| Cytokinetics | 67.67M |
| Praxis Precision Medicines | 7.46M |
| CG Oncology | 6.23M |
| ABIVAX Société Anonyme | 5.33M |
SYRE News
- 2 days ago - Spyre Therapeutics Transcript: Stifel 2026 Virtual Immunology and Inflammation Forum - Transcripts
- 15 days ago - Spyre Therapeutics Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 16 days ago - Spyre Therapeutics Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 17 days ago - Spyre Therapeutics announces 12-week induction data from Part A of SKYLINE trial - TheFly
- 17 days ago - Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations - GlobeNewsWire
- 21 days ago - Spyre Therapeutics Announces Grants of Inducement Awards - GlobeNewsWire
- 22 days ago - Spyre Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 4 weeks ago - Spyre Therapeutics falls -13.2% - TheFly